Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 21;13(43):5699-706.
doi: 10.3748/wjg.v13.i43.5699.

Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model

Affiliations

Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model

You-Hong Yuan et al. World J Gastroenterol. .

Abstract

Aim: To investigate dynamic characteristics and pathological mechanism of signal in rabbit VX-2 tumor model on diffusion-weighted imaging (DWI) after chemoembolization.

Methods: Forty New Zealand rabbits were included in the study and forty-seven rabbit VX-2 tumor models were raised by implanting directly and intrahepatically after abdominal cavity opened. Forty VX-2 tumor models from them were divided into four groups. DWI was performed periodically and respectively for each group after chemoembolization. All VX-2 tumor samples of each group were studied by pathology. The distinction of VX-2 tumors on DWI was assessed by their apparent diffusion coefficient (ADC) values. The statistical significance between different time groups, different area groups or different b-value groups was calculated by using SPSS12.0 software.

Results: Under b-value of 100 s/mm(2), ADC values were lowest at 16 h after chemoembolization in area of VX-2 tumor periphery, central, and normal liver parenchyma around tumor, but turned to increase with further elongation of chemoembolization treatment. The distinction of ADC between different time groups was significant respectively (F = 7.325, P < 0.001; F = 2.496, P < 0.048; F = 6.856, P < 0.001). Cellular edema in the area of VX-2 tumor periphery or normal liver parenchyma around tumor, increased quickly in sixteen h after chemoembolization but, from the 16th h to the 48th h, cellular edema in the area of normal liver parenchyma around tumor decreased gradually and that in the area of VX-2 tumor periphery decreased lightly at, and then increased continually. After chemoembolization, Cellular necrosis in the area of VX-2 tumor periphery was more significantly high than that before chemoembolization. The areas of dead cells in VX-2 tumors manifested low signal and high ADC value, while the areas of viable cells manifested high signal and low ADC value.

Conclusion: DWI is able to detect and differentiate tumor necrotic areas from viable cellular areas before and after chemoembolization. ADC of normal liver parenchyma and VX-2 tumor are influenced by intracellular edema, tissue cellular death and microcirculation disturbance after chemoembolization.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: The area of VX-2 tumor center; B: The area of VX-2 tumor periphery; C: The area of VX-2 tumor outer layer; D: The normal liver parenchyma area around tumor when the values of ADC and signals were measured on DWI and samples were investigated pathologically.
Figure 2
Figure 2
ADC values of different areas on DWI after chemoembolization. A: B-value was 100 s/mm2; B: B-value was 300 s/mm2.
Figure 3
Figure 3
Signal values on DWI when area and b-value was different after chemoembolization. Areas: 1-signal of VX-2 tumor periphery area when b-value was 100 s/mm2; 2-signal of VX-2 tumor center area when b-value was 100 s/mm2; 3-signal of the normal liver parenchyma area around tumor when b-value was 100 s/mm2; 4-signal of VX-2 tumor periphery area when b-value was 300 s/mm2; 5-signal of VX-2 tumor center area when b-value was 300 s/mm2; 6-signal of the normal liver parenchyma area around tumor when b-value was 300 s/mm2.
Figure 4
Figure 4
Image manifestations of hepatic VX-2 tumor on DWI and ADC map when b-value was 100 s/mm2 at 6 h after chemoembolization A: High signal and distinct margin of VX-2 tumor on DWI; B: Low signal of it on the ADC map.
Figure 5
Figure 5
Image manifestations of hepatic VX-2 tumor on DWI and ADC map when b-value was 100 s/mm2 at 48 h after chemoembolization A: High and uneven signal and distinct margin of VX-2 tumor on DWI; B: Low and uneven signal of it on the ADC map.
Figure 6
Figure 6
Cellular edema of different areas after chemoembolization.
Figure 7
Figure 7
A: Cell nest of VX-2 tumor and wide zone of necrosis in the tumor(x 100) and B: cellular edema in the VX-2 tumor (x 400).

Similar articles

Cited by

References

    1. Morimoto M, Shirato K, Sugimori K, Kokawa A, Tomita N, Saito T, Imada T, Tanaka N, Nozawa A, Numata K, et al. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2003;181:65–69. - PubMed
    1. Kubota K, Hisa N, Nishikawa T, Fujiwara Y, Murata Y, Itoh S, Yoshida D, Yoshida S. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging. 2001;26:184–190. - PubMed
    1. Ebied OM, Federle MP, Carr BI, Pealer KM, Li W, Amesur N, Zajko A. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2003;97:1042–1050. - PubMed
    1. Kim HC, Kim AY, Han JK, Chung JW, Lee JY, Park JH, Choi BI. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology. 2002;225:773–780. - PubMed
    1. Shankar S, vanSonnenberg E, Morrison PR, Tuncali K, Silverman SG. Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. AJR Am J Roentgenol. 2004;183:1425–1429. - PubMed

Publication types

MeSH terms